Literature DB >> 22440387

The association of mean glucose level and glucose variability with intensive care unit mortality in patients with severe acute pancreatitis.

Yan-yan Zuo1, Yan Kang, Wan-hong Yin, Bo Wang, Yao Chen.   

Abstract

PURPOSE: The objective of this study was to retrospectively analyze the association of mean glucose level (MGL) and glycemic lability index (GLI; as a measure of glucose variability) with intensive care unit (ICU) mortality in patients with severe acute pancreatitis (SAP).
MATERIALS AND METHODS: Paper-based medical records of patients with SAP who were admitted to the ICU of West China Hospital between July 1, 2005, and July 1, 2010, were analyzed. Glucose measurements, demographic characteristics, clinical features, data on the first and second 24-hour Acute Physiology and Chronic Health Evaluation (APACHE) II scores, and outcomes were obtained. Time-weighted glucose parameters were used. We statistically analyzed the relationship between these variables and both ICU and hospital mortality.
RESULTS: A total of 294 patients with 34,796 glucose measurements were included in the final analysis. The time-weighted MGL was 9.31 ± 1.91 mmol/L, and the median of GLI was 55.27 (mmol/L)(2) h-(1) wk-(1). Intensive care unit mortality was 43.5% and increased progressively as GLI increased, reaching 62.5% of patients with GLI above 115.89 (mmol/L)(2) h-(1) wk-(1). The highest odds ratio for ICU death was found in patients with the highest quartile of GLI: odds ratio, 3.47 (95% confidence interval, 1.76-6.86; P < .000). No such relationship could be found with MGL. Glycemic lability index was better able to predict ICU death than was MGL (the area under the curves were 0.642 vs 0.561, respectively; z test was 2.677; P = .0074). The logistic regression analysis showed that GLI, the second 24-hour APACHE II score, and the number of organ failures upon ICU admission contributed independently to the risk of mortality.
CONCLUSIONS: We observed that GLI was a better predictor of ICU and hospital mortality than was MGL. Together with the second 24-hour APACHE II score and the number of organ failures upon ICU admission, GLI is an independent predictor of mortality in patients with SAP.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22440387     DOI: 10.1016/j.jcrc.2011.12.004

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  7 in total

1.  Glucose Variability Measures as Predictors of Oral Feeding Intolerance in Acute Pancreatitis: A Prospective Pilot Study.

Authors:  Chirag J Jivanji; Varsha M Asrani; Sayali A Pendharkar; Melody G Bevan; Nicola A Gillies; Danielle H E Soo; Ruma G Singh; Maxim S Petrov
Journal:  Dig Dis Sci       Date:  2017-03-14       Impact factor: 3.199

Review 2.  Glycemic variability in hospitalized patients: choosing metrics while awaiting the evidence.

Authors:  Susan S Braithwaite
Journal:  Curr Diab Rep       Date:  2013-02       Impact factor: 4.810

3.  Effect of the approach to insulin therapy on glycaemic fluctuations and autonomic tone in hospitalized patients with diabetes.

Authors:  K M Dungan; K Osei; C Sagrilla; P Binkley
Journal:  Diabetes Obes Metab       Date:  2013-02-17       Impact factor: 6.577

4.  Glucose variability during the early course of acute pancreatitis predicts two-year probability of new-onset diabetes: A prospective longitudinal cohort study.

Authors:  Sakina H Bharmal; Jaelim Cho; Juyeon Ko; Maxim S Petrov
Journal:  United European Gastroenterol J       Date:  2022-02-20       Impact factor: 4.623

Review 5.  Glycemic control in critically ill: A moving target.

Authors:  Subhash Todi
Journal:  Indian J Crit Care Med       Date:  2014-04

6.  Association between glycemic variability and mortality: How robust is the evidence?

Authors:  John Victor Peter; Raj Kumar Mani
Journal:  Indian J Crit Care Med       Date:  2014-05

7.  Glycemic variability and outcome in critically ill.

Authors:  Subhash Todi; Mahuya Bhattacharya
Journal:  Indian J Crit Care Med       Date:  2014-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.